PAIN TRIGGERS
Standard treatments, relaxation techniques, and ADHD medications fail to resolve or actually worsen the internal anxiety/checking cycle.
Difficulty distinguishing between ADHD executive dysfunction and anxiety/OCD-induced paralysis.
SaaS· Neurodivergent individuals (diagnosed with ADHD and/or autism)Pain 8.00/10WTP 8.0/10Market 6.0/10Validation 8.0Confidence 85%Jun 29, 2026
DiffDiag: Neurodivergent Symptom-Pattern Tracker for Complex Co-morbidities
Neurodivergent individuals suffer from chronic internal anxiety and checking loops that mimic or exacerbate executive dysfunction, leading doctors to prescribe standard ADHD stimulants or SSRIs that can fail or worsen the condition.
adhdanalyticsdata-managementhealthcaremental-healthneurodivergentproductivitysaas
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Individuals with neurodivergent diagnoses (ADHD/autism) suffer from chronic internal anxiety and obsessive checking cycles that mimic or override executive dysfunction, leading to ineffective medication treatments and potential misdiagnosis.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Anybody experiencing this? Been diagnosed with ADHD but it’s actually something else
ADHD13
"I wonder if there are confusion between being paralyzed due to anxiety and intrusive thoughts and not being able to focus because your mind is too busy."
commentI have the same worry for someone else. I’ve been looking into the probability that someone with pure ocd is misdiagnosed and if adhd medication can make their ocd worse. I wonder if there are confusion between being paralyzed due to anxiety and intrusive thoughts and not being able to focus because your mind is too busy. Not a doctor or anything but I have adhd and seeing someone you love being diagnosed with the same thing but just getting worse feels a bit hopeless.I know it represents differently, but some things in life should be questioned, not to make someone feel “invalidated” but to make sure they are truly getting the right help they need. I hope this makes sense .
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
Neurodivergent individuals (diagnosed with ADHD and/or autism)Neurodivergent Adults With Co Morbidities
Individuals experiencing chronic internal anxiety and obsessive symptom-checking cycles that mask or complicate their ADHD/autism treatments.
Context
Identify the correct root cause of chronic internal stress/anxiety, stop the constant symptom-checking cycle, and find an effective treatment or medication that restores cognitive focus and social spontaneity.
Constantly monitoring one's own internal state to see if the anxiety symptom is still present.
Independently researching overlapping conditions (like pure OCD) and questioning clinical diagnoses to find alternative explanations.
Current Workarounds
Manually tracking medication reactions in notes apps or paper journals
Obsessively searching subreddits like r/ADHD, r/AutisticWithADHD, and r/OCD for matching anecdotes
Aggressively testing standard relaxation and mindfulness apps that often backfire
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
ADHD medications (like Ritalin) do not alleviate, and may exacerbate, underlying obsessive or anxiety-driven checking behaviors.
Standard anxiety/mood stabilization medications (up to 200mg Sertraline, Carbamazepine) can fail completely for this specific internal 'alarm' manifestation.
Common somatic and mindfulness interventions (breathing, vagus nerve stimulation) can backfire, escalating the user's focus on the anxiety.
Clinical diagnostic processes struggle to accurately differentiate or rule out overlapping conditions like OCD, ADHD, and autism.
OPPORTUNITY & VALUE
Why Now
Repeated complaints focus on traditional ADHD stimulants failing or worsening deep internal anxiety, alongside high diagnostic difficulty separating ADHD executive dysfunction from anxiety/OCD paralysis.
Value Proposition
Unlike generic mood trackers or mindfulness apps that escalate self-monitoring anxiety, this tool isolates obsessive checking behavior from genuine attention deficits and visualizes how specific medications affect both distinctly.
Product Direction
A specialized, non-triggering micro-journaling and objective symptom-tracking app designed specifically to map out relationships between focus, internal 'alarms', obsessive checking, and medication side effects, producing structured reports for psychiatric visits.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$12/moBilled monthly, cancel anytime, 14-day free trial
Model
SaaS subscription
WILLINGNESS TO PAY
Users are spending hundreds on failed psychiatric appointments, medication copays, and alternative supplements. A clear diagnostic log that saves even one medical consultation easily justifies a $12 cost.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Separate your ADHD from anxiety to find the medication that actually works.”
A specialized, non-triggering micro-journaling and objective symptom-tracking app designed specifically to map out relationships between focus, internal 'alarms', obsessive checking, and medication side effects, producing structured reports for psychiatric visits.
Core Features
Ultra-low-friction 'state check-in' widget that records tension, focus, and checking behaviors without triggering hyper-fixation
Time-series correlation engine mapping physical tension against medication dosage timelines
One-click structured data export optimized for presentation to a treating psychiatrist
Weekly Roadmap
1
W1-W2
Core logging engine built with passive, non-triggering check-ins.
- •Design non-triggering UI for logging focus vs internal stress
- •Build database schema for medication logs and symptom timestamps
- •Implement basic local dashboard visualization
2
W3-W4
Correlation analytics and clinical export feature operational.
- •Develop background correlation script matching medication times to anxiety spikes
- •Generate automated PDF report summary designed for medical doctors
- •Add simple push-notification flow optimized to prevent user hyper-fixation
3
W5
Private beta testing with 15 community-sourced neurodivergent adults.
- •Recruit 15 beta testers from r/AutisticWithADHD and r/OCD
- •Gather feedback on whether the tracking process feels anxiety-inducing
- •Integrate Stripe billing engine and trial access walls
4
W6
Public launch with initial marketing deployment to target subreddits.
- •Publish open launch thread on relevant neurodivergent forums
- •Publish a resource guide on 'How to show tracking data to your psychiatrist'
- •Measure trial-to-paid conversion rates
Launch Strategy
Target niche neurodivergent communities, Reddit support spaces (r/AutisticWithADHD, r/ADHDUK, r/OCD), and psychiatric professionals who specialize in adult neurodivergent co-morbidities.
RISKS & ASSUMPTIONS
Top Risks
Exacerbating checking behaviors
Requiring users to log details might accidentally become a new compulsive checkpoint in their daily anxiety cycle.
Medical disclaimer liabilities
Users may interpret data correlations as definitive medical diagnoses, risking friction with healthcare rules if not carefully guarded.
Low longitudinal retention
Once a user aligns their medication regimen with their provider, their immediate operational pain decreases, risking high user churn.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 2 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "analytics", "data-management", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "DiffDiag: Neurodivergent Symptom-Pattern Tracker for Complex Co-morbidities" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.